175 related articles for article (PubMed ID: 2825494)
1. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria.
Stomper PC; Fung CY; Socinski MA; Jochelson MS; Garnick MB; Richie JP
AJR Am J Roentgenol; 1987 Dec; 149(6):1187-90. PubMed ID: 2825494
[TBL] [Abstract][Full Text] [Related]
2. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.
Hilton S; Herr HW; Teitcher JB; Begg CB; Castéllino RA
AJR Am J Roentgenol; 1997 Aug; 169(2):521-5. PubMed ID: 9242768
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
4. Predictive models for lymph node metastases in patients with testicular germ cell tumors.
Mao Y; Hedgire S; Prapruttam D; Harisinghani M
Abdom Imaging; 2015 Oct; 40(8):3196-205. PubMed ID: 26288987
[TBL] [Abstract][Full Text] [Related]
5. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
6. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
Howard SA; Gray KP; O'Donnell EK; Fennessy FM; Beard CJ; Sweeney CJ
AJR Am J Roentgenol; 2014 Oct; 203(4):W415-20. PubMed ID: 25247970
[TBL] [Abstract][Full Text] [Related]
7. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection.
Baessler B; Nestler T; Pinto Dos Santos D; Paffenholz P; Zeuch V; Pfister D; Maintz D; Heidenreich A
Eur Radiol; 2020 Apr; 30(4):2334-2345. PubMed ID: 31828413
[TBL] [Abstract][Full Text] [Related]
8. Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.
Hudolin T; Kastelan Z; Knezevic N; Goluza E; Tomas D; Coric M
Int J Surg Pathol; 2012 Feb; 20(1):15-8. PubMed ID: 22180527
[TBL] [Abstract][Full Text] [Related]
9. Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial.
Laukka M; Mannisto S; Beule A; Kouri M; Blomqvist C
Acta Oncol; 2020 Jun; 59(6):660-665. PubMed ID: 32048533
[No Abstract] [Full Text] [Related]
10. Computed tomography in early stages of testicular carcinoma. Size of normal retroperitoneal lymph nodes and lymph nodes in patients with metastases in stage II A. A SWENOTECA study: Swedish-Norwegian Testicular Cancer Project.
Forsberg L; Dale L; Høiem L; Magnusson A; Mikulowski P; Olsson AM; Ous S; Stenwig AE
Acta Radiol Diagn (Stockh); 1986; 27(5):569-74. PubMed ID: 3026141
[TBL] [Abstract][Full Text] [Related]
11. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.
Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP
J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805
[TBL] [Abstract][Full Text] [Related]
12. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
13. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
[TBL] [Abstract][Full Text] [Related]
14. Re: Craniocaudal Retroperitoneal Node Length as a Risk Factor for Relapse from Clinical Stage I Testicular Germ Cell Tumor.
Richie JP
J Urol; 2015 Dec; 194(6):1633. PubMed ID: 26582668
[No Abstract] [Full Text] [Related]
15. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
17. Reliability of diagnostic imaging after orchiectomy alone in follow-up of clinical stage I testicular carcinoma: excessive cost with potential risk.
Tesoro-Tess JD; Pizzocaro G; Zanoni F; Balzarini L; Ceglia E; Petrillo R; Musumeci R
Lymphology; 1987 Sep; 20(3):161-5. PubMed ID: 3682940
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
19. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Brown JA; Bihrle R; Foster RS
Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
[TBL] [Abstract][Full Text] [Related]
20. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor.
Lien HH; Stenwig AE; Ous S; Fosså SD
Acta Radiol Diagn (Stockh); 1986; 27(2):199-203. PubMed ID: 3716866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]